Skip to main content
. 2021 Apr 14;11(4):703. doi: 10.3390/diagnostics11040703

Figure 2.

Figure 2

Boxplot graphs demonstrating the serum expression levels of miR-137 in patients with chest pain and suspected for CAD; higher expression levels of miR-137 (a), FTHL-17 (b), miR-106b (d) and ANAPC11 (e) were significantly associated with CAD; lnc-CTB89H12.4 was downregulated (c); Abbreviations: CAD: coronary artery disease, STEMI: ST-segment elevation myocardial infarction, FTHL-17: Ferritin heavy chain like 17, ANAPC11: anaphase promoting complex subunit, p < 0.05 considered significant, ns: no-significant difference.